Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Novavax Inc
Recent news which mentions Novavax Inc
< Previous
1
2
3
4
Next >
FDA may pull authorization of Pfizer’s Covid vaccine for children under 5
August 12, 2025
Tags
Business News
Novavax Inc
Pharmaceuticals
From
CNBC.com News
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
June 30, 2025
Tags
Health care industry
Companies
Biotechnology
From
CNBC.com News
Healthy Returns: Novavax scores narrower Covid vaccine approval after delay
May 20, 2025
Tags
Moderna Inc
Biotech and Pharmaceuticals
Pfizer Inc
From
CNBC.com News
Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.
March 31, 2025
Tags
Pfizer Inc
US: News
Government and politics
From
CNBC.com News
Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary
February 04, 2025
Tags
Pfizer Inc
US: News
Health care industry
From
CNBC.com News
5 things to know before the stock market opens Tuesday
January 14, 2025
Tags
Politics
Business
5 Things to Know
From
CNBC.com News
Moderna stock plunges 18% after company lowers 2025 sales forecast by $1 billion
January 13, 2025
Tags
Business News
Novavax Inc
Pharmaceuticals
From
CNBC.com News
Cramer's Lightning Round: 'I'm not a fan of Novavax'
December 09, 2024
Tags
Stock markets
Novavax Inc
Business News
From
CNBC.com News
Vaccine maker stocks fall on reports Trump plans to tap RFK Jr. to lead HHS
November 14, 2024
Tags
Biontech SE
Business News
Novavax Inc
From
CNBC.com News
Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plunge
October 16, 2024
Tags
Moderna Inc
Science
Biotech and Pharmaceuticals
From
CNBC.com News
FDA authorizes Novavax’s updated Covid vaccine, paving way for fall rollout
August 30, 2024
Tags
Health & Science
Novavax Inc
Pharmaceuticals
From
CNBC.com News
Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines
August 27, 2024
Tags
Dexcom Inc
Biotech and Pharmaceuticals
Moderna Inc
From
CNBC.com News
FDA approves updated Pfizer, Moderna Covid vaccines as virus surges; shots to be available within days
August 22, 2024
Tags
Health & Science
Social issues
Breaking news
From
CNBC.com News
Cramer's Lightning Round: 'Let's stay away' from Unity Software
June 14, 2024
Tags
Business
Ardagh Metal Packaging SA
stocks
From
CNBC.com News
Healthy Returns: What we know about the next round of Covid vaccines
June 12, 2024
Tags
Moderna Inc
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
June 10, 2024
Tags
Business
Biotech and Pharmaceuticals
Moderna Inc
From
CNBC.com News
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
May 13, 2024
Tags
US: News
Pfizer Inc
Health care industry
From
CNBC.com News
5 things to know before the stock market opens Friday
May 10, 2024
Tags
Politics
Markets
5 Things to Know
From
CNBC.com News
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shots
May 10, 2024
Tags
Sanofi SA
Health & Science
Novavax Inc
From
CNBC.com News
Novavax misses quarterly estimates, but vaccine maker narrows losses as it slashes costs
February 28, 2024
Tags
Health & Science
Novavax Inc
Pharmaceuticals
From
CNBC.com News
Novavax to settle dispute over canceled Covid vaccine purchase agreement
February 22, 2024
Tags
Business
Biotech and Pharmaceuticals
Breaking news
From
CNBC.com News
Cramer's Lightning Round: 'Nothing good to say' about Novavax
December 07, 2023
Tags
Coinbase Global Inc
Atkore International Group Inc
U/S/ Markets
From
CNBC.com News
Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them
November 30, 2023
Tags
Business
Moderna Inc
Science
From
CNBC.com News
Moderna posts quarterly loss as company takes $1.3 billion write-down on unused Covid shots
November 02, 2023
Tags
Moderna Inc
Biotech and Pharmaceuticals
Business
From
CNBC.com News
Pfizer's combination Covid, flu vaccine will move to final-stage trial after positive data
October 26, 2023
Tags
Health & Science
Business News
Breaking news
From
CNBC.com News
Novavax's updated Covid vaccine can still catch up to Pfizer, Moderna shots this fall
October 07, 2023
Tags
Walgreens Boots Alliance Inc
Biotech and Pharmaceuticals
Science
From
CNBC.com News
FDA approves updated Novavax Covid vaccine as Pfizer, Moderna shots roll out in U.S.
October 03, 2023
Tags
Companies
Coronavirus
Biotechnology
From
CNBC.com News
Cramer's Lightning Round: GE Healthcare is a buy
September 28, 2023
Tags
GE HealthCare Technologies Inc
Marvell Technology Inc
Stock markets
From
CNBC.com News
Uninsured Americans can still get free Covid boosters — here's how to find them
September 19, 2023
Tags
Business News
Pharmaceuticals
Novavax Inc
From
CNBC.com News
New Covid vaccines could reach Americans as soon as Thursday – here's what you need to know
September 13, 2023
Tags
Pharmaceuticals
Novavax Inc
Business News
From
CNBC.com News
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.